IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders

Abstract

Previous treatment with IV immunoglobulin was associated with a reduced risk of developing Alzheimer disease and related disorders (ADRD) in this study. Evidence from additional studies is needed to evaluate the relationship between IVIg exposure and ADRD diagnosis.